5 completed, 1 active not recruiting, 1 recruiting, 1 suspended. 9 Phase 2, 2 Phase 1, 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 9 | Completed 5, Active not recruiting 1, Recruiting 1, Suspended 1, Unknown 1 |
| Phase 1 | 2 | Completed 1, Suspended 1 |
| Phase 3 | 1 | Unknown 1 |
Follow Femur Head Necrosis: new trials by email Literature Review of Femur Head Necrosis trials Research Report on Femur Head Necrosis
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| The Study of Early Stage Osteonecrosis of Femoral Head With Human Umbilical Cord Mesenchymal Stem Cells (19#iSCLife®-ONFH) Allogeneic umbilical cord mesenchymal stem cells (SCLnow 19#), core decompression - Osteonecrosis of Femoral Head | Phase 1 / Phase 2 | Suspended | Sclnow Biotechnology Co., Ltd. | 30 | 2026-12-31 | 2026-04-23 |
| Alendronate for Osteonecrosis in Adults With Sickle Cell Disease Alendronate Sodium - Sickle Cell Disease, Sickle Cell Anemia | Phase 2 | Recruiting | University of California, Davis | 30 | 2026-03-09 | 2026-07-16 |
| A Phase II Trial of RAB001 (LLP2A-Alendronate) for Steroid-Induced Early-Stage Osteonecrosis of the Femoral Head RAB001 high dose, RAB001 medium dose, RAB001 low dose - Osteonecrosis, Osteonecrosis of the Femoral Head | Phase 2 | Active not recruiting | ZhongShan LaiBo RuiChen BioMedicine Co.,Ltd. | 161 | 2024-12-24 | 2026-03-24 |
| Mesenchymal Stem Cells in Osteonecrosis of the Femoral Head XCEL-MT-OSTEO-ALPHA, Standard treatment - Avascular Necrosis of Femur Head | Phase 1 / Phase 2 | Completed | Banc de Sang i Teixits | 23 | 2015-05-05 | 2020-01-21 |
| Evaluation of Mesenchymal Stem Cells to Treat Avascular Necrosis of the Hip Cultured autologous Mesenchymal Cells - Avascular Necrosis of the Femoral Head | Phase 2 | Completed | Universidad Autonoma de Madrid | 26 | 2014-02-01 | 2021-10-14 |
| PHASE II CLINICAL TRIAL Prospective, Open, Nonrandomized Treatment of Osteonecrosis of the Femoral Head by the Administration of Autologous Mesenchymal Stem Cells bone marrow aspirate - Osteonecrosis of the Femoral Head | Phase 2 | Completed | Red de Terapia Celular | 3 | 2012-07-01 | 2017-03-30 |
| Implantation of Bone Marrow Cells to Treat Avascular Necrosis of Femoral Head (ANFH) core decompression, Enriched BMCs implantation combined with core decompression - Avascular Necrosis of Femur Head | Phase 2 / Phase 3 | Unknown | Guangdong Provincial People's Hospital | 60 | 2009-03-01 | 2012-08-14 |
| Effectiveness of Two Types of Treatment in Restoring Muscle After Hip or Knee Surgery Essential amino acid supplement, Ketoconazole, Placebo - Hip Fracture, Osteoarthritis | Phase 2 | Completed | University of Arkansas | 40 | 2006-10-01 | 2014-06-02 |
| Autologous Osteoblastic Cells Implantation to Early Stage Osteonecrosis of the Femoral Head Core decompression/PREOB® implantation, Core decompression/BMC implantation - Avascular Necrosis of Femur Head | Phase 2 | Completed | Erasme University Hospital | 82 | 2003-10-01 | 2016-09-07 |
Legg-Calve-Perthes Disease (4) · Osteonecrosis (4) · Musculoskeletal Diseases (2) · Anemia, Sickle Cell (1) · Bone Diseases (1) · Hip Fractures (1) · Osteoarthritis (1)
Bone Diseases (8) · Necrosis (8) · Pathologic Processes (8) · Pathological Conditions, Signs and Symptoms (8) · Musculoskeletal Diseases (7) · Osteonecrosis (5) · Anemia (1) · Anemia, Hemolytic (1) · Anemia, Hemolytic, Congenital (1) · Arthritis (1) · Congenital, Hereditary, and Neonatal Diseases and Abnormalities (1) · Femoral Fractures (1) · Fractures, Bone (1) · Genetic Diseases, Inborn (1)
Alendronate (2) · Ketoconazole (1)
Banc de Sang i Teixits (1) · Erasme University Hospital (1) · Guangdong Provincial People's Hospital (1) · Red de Terapia Celular (1) · Sclnow Biotechnology Co., Ltd. (1) · Universidad Autonoma de Madrid (1) · University of Arkansas (1) · University of California, Davis (1) · ZhongShan LaiBo RuiChen BioMedicine Co.,Ltd. (1)
Spain (3) · China (2) · United States (2) · Belgium (1) · France (1) · Germany (1) · Italy (1)
Arny Ferrando, PhD (1) · Enrique Gomez-Barrena, Prof (1) · Lei Guo, Dr. (1) · Oyebimpe O Adesina, MD, MS (1)
PMID 25315149, PMID 25769789, PMID 32678055, PMID 33535589
K23HL148310 (1), R01AR052293 (1)